(Q40503823)

21 September 2017

title

Severe bone marrow aplasia following imatinib mesylate in a patient with chronic myelogenous leukemia (English)

1 reference

21 September 2017

1 reference

Nilesh Lokeshwar

1

1 reference

21 September 2017

Lalit Kumar

series ordinal

2

1 reference

21 September 2017

Mamta Kumari

series ordinal

3

1 reference

21 September 2017

publication date

1 May 2005

1 reference

21 September 2017

1 reference

21 September 2017

volume

46

1 reference

21 September 2017

issue

5

1 reference

21 September 2017

page(s)

781-784

1 reference

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190500046778

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500046778

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500046778

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500046778

ST1571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500046778

Infusion of peripheral blood stem cells collected at diagnosis, with maintenance of the treatment, resulted in Ph-negative recovery in a chronic myeloid leukaemia patient in persisting aplasia on STI-571 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500046778

Severe cytopenias associated with the sequential use of busulphan and interferon-alpha in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500046778

Practical management of patients with chronic myeloid leukemia receiving imatinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500046778

10.1080/10428190500046778

21 January 2018

Identifiers

DOI

1 reference

release_eojrnhtphrfipgixxhy3fygsvm

21 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/eojrnhtphrfipgixxhy3fygsvm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference